Medical News

RSS

Positive results from Alnylam's ALN-VSP Phase I trial for liver cancer

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has completed its Phase I study with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement.

1 Aug 2011

Merck submits ridaforolimus MAA with EMA for treatment of metastatic soft-tissue, bone sarcomas

ARIAD Pharmaceuticals, Inc. today announced that its ridaforolimus partner, Merck, has submitted a marketing authorization application (MAA) for ridaforolimus with the European Medicines Agency.

1 Aug 2011

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

Cubist Pharmaceuticals, Inc. today announced the initiation of a pivotal Phase 3 trial of CXA-201 in patients with complicated urinary tract infections.

1 Aug 2011

PathoGenetiX receives $4.0 million in first close of Series B financing

PathoGenetiX Inc., today announced that the Company has received $4.0 million in the first closing of its Series B financing.

1 Aug 2011

Nature Biotechnology publishes BGI, GT Life Sciences' study on CHO K1 genome

BGI, the world's largest genomics organization, and GT Life Sciences, Inc., a privately held biotechnology company that utilizes a proven metabolic modeling and experimental platform to drive the discovery and design of new products and processes for the life sciences field, announced today that their collaborative study on the genomic sequence of the Chinese hamster ovary (CHO) K1 cell line was published July 31, 2011 online in Nature Biotechnology.

1 Aug 2011

Mon General Hospital to install Merge cardiology and information solutions

Merge Healthcare, a leading provider of enterprise imaging and interoperability solutions, announced today that Mon General Hospital, one of West Virginia's leading acute-care community hospitals, located in Morgantown, is installing its full suite of enterprise-level cardiology solutions.

1 Aug 2011

SXC to launch enhanced Coordination of Benefits service in the state Medicaid market

SXC Health Solutions Corp., a leading provider of technology and pharmacy benefit management services, is launching the industry's first automated, enhanced Coordination of Benefits service in the State Fee-For-Service Medicaid market.

1 Aug 2011

Artificial nanoparticles have direct effect on heart rate and rhythm

Artificial nanoparticles are becoming increasingly pervasive in modern life. However, their influence on our health and the mechanisms by which they affect the human body remain largely shrouded in mystery.

1 Aug 2011

Electrochem launches new company website and corporate brand

Electrochem Solutions, Inc. announced today the launch of its rebranded and redesigned company website.

1 Aug 2011

Stealth presents Bendavia at AHA's Cardiovascular Scientific Sessions

Stealth Peptides Inc. (Stealth), a privately held biopharmaceutical company developing innovative mitochondrial therapies for diseases with unmet medical needs, presented its lead clinical candidate, Bendavia, during the 2011 American Heart Association's (AHA) Cardiovascular Scientific Sessions.

1 Aug 2011

Affymetrix to commercialize four Axiom genotyping arrays for the major populations

Affymetrix, Inc. today announced plans to commercialize four Axiom population-optimized arrays used to analyze 100,000 samples collected from volunteers in one of the nation's largest and most diverse genomics projects funded by the National Institutes of Health.

1 Aug 2011

Tips for obtaining life insurance after heart attack

Life Quotes, Inc. wants heart attack survivors to know that, while it may be tough to get a life insurance policy, it's not impossible. Heart disease is the #1 cause of death in America and many survivors are unaware of the life insurance options that may be open to them.

1 Aug 2011

Fischer retains TransMedia to launch Israel's most popular sunscreen in the U.S.

Fischer Pharmaceutical Ltd., a multi-national company specializing in R&D and manufacture of a wide variety of skin and health care products, has retained TransMedia Group to introduce Israel's most popular sunscreen, Dr. Fischer ULTRASOL, in the United States.

1 Aug 2011

Researchers identify new plasma membrane sculpting protein

The research group of Professor Pekka Lappalainen at the Institute of Biotechnology, University of Helsinki, has identified a previously unknown mechanism which modifies the structure of plasma membranes in intestinal epithelial cells.

1 Aug 2011

Intensive glycaemic control may negatively affect a person's quality of life

Research published in The Cochrane Library found that the risk of death and cardiovascular disease, such as stroke, was unchanged whether glucose control was intense or conventional.

1 Aug 2011

Scientists reveal genetic region that increases risk of meningioma

Cancer Research UK funded scientists have conducted the first whole-genome scan of the brain tumour meningioma and revealed a genetic region that increases the risk of developing the disease, according to research published in Nature Genetics today.

1 Aug 2011

Myb protein suppression can help eliminate acute myelogenous leukemia

A team of scientists at Cold Spring Harbor Laboratory (CSHL) has laid bare the mechanism behind a phenomenon called oncogene addiction in mice suffering from a form of leukemia that mimics acute myelogenous leukemia (AML) in humans.

1 Aug 2011

Power plant emissions do not contribute to lake acidification

During the 1970s and 1980s, researchers and policymakers became increasingly worried about multiple consequences of acidic emissions of sulfur dioxide and nitrogen oxides from the stacks of power stations, and eventually they were controlled. In Europe, there was much concern about the effects on Sweden's many lakes, which were found to be in some cases strikingly acidic.

1 Aug 2011

New device can produce blood-based diagnostic results in minutes

Samuel K. Sia, assistant professor of biomedical engineering at Columbia Engineering, has developed an innovative strategy for an integrated microfluidic-based diagnostic device-in effect, a lab-on-a-chip-that can perform complex laboratory assays, and do so with such simplicity that these tests can be carried out in the most remote regions of the world.

1 Aug 2011

Kenya Medical Services Minister to establish African Cancer Foundation

When Anyang' Nyong'o, Medical Services Minister of Kenya, returned cancer-free to his native land in March of this year, he made a commitment to the people of Kenya. "My experience is a wake-up call for us in Kenya," he proclaimed.

1 Aug 2011